REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 180 filers reported holding REGENXBIO INC in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,414,128 | +437.1% | 85,913 | +552.3% | 0.04% | +400.0% |
| Q2 2023 | $263,288 | -57.0% | 13,171 | -59.3% | 0.01% | -58.8% |
| Q1 2023 | $612,155 | +92.3% | 32,372 | +130.6% | 0.02% | +88.9% |
| Q4 2022 | $318,405 | -77.5% | 14,039 | -67.1% | 0.01% | -86.6% |
| Q1 2022 | $1,416,000 | +400.4% | 42,655 | +387.4% | 0.07% | +219.0% |
| Q1 2020 | $283,000 | +21.5% | 8,751 | +12.0% | 0.02% | +31.2% |
| Q1 2018 | $233,000 | -52.0% | 7,815 | -68.9% | 0.02% | -74.2% |
| Q1 2017 | $485,000 | – | 25,109 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |